C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation
Two consecutive multi-center phase II trials were designed to prove the hypothesis, whether therapeutic modeling of tumor-associated inflammatory processes could result in improved tumor response. Therapy in both trials consisted of low-dose capecitabine 1g/m2 twice daily p.o. for 14 days, every 3 w...
Main Authors: | Albrecht Reichle, Jochen Grassinger, Klaus Bross, Jochen Wilke, Thomas Suedhoff, Bernhard Walter, Wolf-Ferdinand Wieland, Anna Berand, Reinhard Andreesen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2006-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/117727190600100017 |
Similar Items
-
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation
by: Albrecht Reichle, et al.
Published: (2006-01-01) -
Der Einfluss des AT2-interacting Protein 1 (ATIP1) auf die Kontraktilität und den Kalziumstoffwechsel von ventrikulären Herzmuskelzellen
by: Reichle, Jochen
Published: (2016) -
Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
by: Sai Krishnaraya Doppalapudi, et al.
Published: (2021-08-01) -
Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma
by: Martin Pilskog, et al.
Published: (2017-08-01) -
Solitary metastatic clear cell carcinoma to the spleen
by: Mohamed A. Zayed, et al.
Published: (2011-10-01)